Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cocrystal Pharma Inc (COCP)
NASDAQ:COCP
Cocrystal Pharma (COCP) Stock Price & Analysis
964 Followers
COCP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.74 - $3.72
Previous Close$1.95
Volume14.95K
Average Volume (3M)31.47K
Market Cap
$19.84M
Enterprise ValueN/A
Total Cash (Recent Filing)$32.49M
Total Debt (Recent Filing)$176.00K
Price to Earnings (P/E)-0.2
Beta1.28
Next Earnings
Nov 13, 2023EPS Estimate
-$0.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.00
Shares Outstanding10,173,790
10 Day Avg. Volume19,789
30 Day Avg. Volume31,473
Standard Deviation0.35
R-Squared0.03
Alpha-0.00671
Financial Highlights & Ratios
Price to Book (P/B)0.62
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$11.00Price Target Upside464.10% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Cocrystal Pharma News
Pre-EarningsCocrystal Pharma (COCP) Q2 Earnings Cheat Sheet
Pre-EarningsCocrystal Pharma (COCP) Q1 Earnings Cheat Sheet
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
COCP FAQ
What was Cocrystal Pharma Inc’s price range in the past 12 months?
Cocrystal Pharma Inc lowest stock price was $1.74 and its highest was $3.72 in the past 12 months.
What is Cocrystal Pharma Inc’s market cap?
Currently, no data Available
When is Cocrystal Pharma Inc’s upcoming earnings report date?
Cocrystal Pharma Inc’s upcoming earnings report date is Nov 13, 2023 which is in 45 days.
How were Cocrystal Pharma Inc’s earnings last quarter?
Cocrystal Pharma Inc released its earnings results on Aug 14, 2023. The company reported -$0.5 earnings per share for the quarter, beating the consensus estimate of -$0.58 by $0.08.
Is Cocrystal Pharma Inc overvalued?
According to Wall Street analysts Cocrystal Pharma Inc’s price is currently Undervalued.
Does Cocrystal Pharma Inc pay dividends?
Cocrystal Pharma Inc does not currently pay dividends.
What is Cocrystal Pharma Inc’s EPS estimate?
Cocrystal Pharma Inc’s EPS estimate is -$0.53.
How many shares outstanding does Cocrystal Pharma Inc have?
Cocrystal Pharma Inc has 10,173,790 shares outstanding.
What happened to Cocrystal Pharma Inc’s price movement after its last earnings report?
Cocrystal Pharma Inc reported an EPS of -$0.5 in its last earnings report, beating expectations of -$0.58. Following the earnings report the stock price went up 4.152%.
Which hedge fund is a major shareholder of Cocrystal Pharma Inc?
Currently, no hedge funds are holding shares in COCP
---
Cocrystal Pharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.00 (464.10% Upside)
$11.00 (464.10% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 3.9%
Last 30 Days ▼ 3.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.93%
12-Months-Change
Fundamentals
Return on Equity
-46.52%
Trailing 12-Months
Asset Growth
-30.74%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cocrystal Pharma Inc
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.
---
Top 5 ETFs holding COCP
Vanguard Total Stock Market ETF
$574.08K
Up to five ETFs with an Outperform Smart Score that hold COCP. The ETFs are listed according to market value of COCP within the ETF
---